CAS 208038-28-2
:(3R,4R,6R)-6-[(4R)-4-[(3R,5S,7S,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid
Description:
The chemical substance with the name "(3R,4R,6R)-6-[(4R)-4-[(3R,5S,7S,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid" is a complex organic molecule characterized by multiple stereocenters and functional groups. It features a tetrahydropyran ring, which contributes to its cyclic structure, and contains several hydroxyl (-OH) groups that enhance its solubility and reactivity. The presence of a pentanoyl moiety indicates potential biological activity, possibly related to its interaction with biological membranes or enzymes. The intricate stereochemistry suggests that this compound may exhibit specific biological properties, potentially influencing its pharmacological profile. Its CAS number, 208038-28-2, allows for precise identification in chemical databases, facilitating research and application in fields such as medicinal chemistry or biochemistry. Overall, this substance exemplifies the complexity often found in natural products or synthetic analogs with potential therapeutic implications.
Formula:C30H48O10
InChI:InChI=1/C30H48O10/c1-14(4-7-21(33)39-28-25(36)23(34)24(35)26(40-28)27(37)38)17-5-6-18-22-19(9-11-30(17,18)3)29(2)10-8-16(31)12-15(29)13-20(22)32/h14-20,22-26,28,31-32,34-36H,4-13H2,1-3H3,(H,37,38)/t14-,15+,16-,17-,18+,19+,20+,22?,23-,24-,25?,26?,28+,29+,30-/m1/s1
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
β-D-Glucopyranuronic acid, 1-[(3α,5β,7β)-3,7-dihydroxycholan-24-oate]
CAS:Formula:C30H48O10Color and Shape:SolidMolecular weight:568.6961Ursodeoxycholic acid acyl-β-D-glucuronide
CAS:<p>Ursodeoxycholic acid acyl-b-D-glucuronide (UDCA) is a synthetic bile acid that is used to treat liver diseases such as cirrhosis, primary biliary cirrhosis and cholelithiasis. UDCA inhibits the enzyme 7α-hydroxylase in the liver, which converts cholesterol into bile acids. This prevents the formation of lithocholic acid from cholesterol and the accumulation of lipids in the liver. UDCA also suppresses inflammatory cytokines and oxidative stress by inhibiting NF-κB activation.Supplied as the sodium salt</p>Formula:C30H48O10Purity:Min. 95%Color and Shape:PowderMolecular weight:568.7 g/mol
